Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

25
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
25
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

1.1K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.1K
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

44
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
44
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

64
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
64
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

1.0K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.0K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

60
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
60

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex Influences Penumbral Leukocyte Mobilization after Severe TBI.

Neurocritical care·2026
Same author

PulseSelect vs FARAPULSE pulsed field ablation: Comparative analysis of myocardial, neural-injury and hemolysis biomarkers and short-term outcomes.

International journal of cardiology. Heart & vasculature·2026
Same author

[Perioperative complications during transvenous pacemaker and defibrillator implantation].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

[Device treatment in adults with congenital heart defects].

Herzschrittmachertherapie & Elektrophysiologie·2026
Same author

Utility of Serial Cranial Ultrasound in Preterm Infants.

American journal of perinatology·2025
Same author

Structural details of helix-mediated multimerization of the conserved region of TDP-43 C-terminal domain.

Nature communications·2025

Related Experiment Video

Updated: Aug 9, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K

[Arrhythmias : Update on ablations and devices].

Victoria Johnson1, Jörn Schmitt2,3

  • 1Med. Klinik I, Abteilung für Kardiologie und Angiologie, UKGM Gießen, Klinikstraße 33, 35392, Gießen, Deutschland. victoria.johnson@innere.med.uni-giessen.de.

Herz
|February 23, 2023
PubMed
Summary

Innovative pulsed field ablation (PFA) and radiofrequency ablation (RF) techniques show high success and safety rates for atrial fibrillation (AF) treatment. Advancements in ventricular tachycardia diagnostics and leadless pacing also offer improved patient outcomes.

Keywords:
Atrial fibrillationElectroporationHis-bundle pacingInvasive electrophysiologyLeft bundle branch pacing

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Remote Magnetic Navigation for Accurate, Real-time Catheter Positioning and Ablation in Cardiac Electrophysiology Procedures
09:13

Remote Magnetic Navigation for Accurate, Real-time Catheter Positioning and Ablation in Cardiac Electrophysiology Procedures

Published on: April 21, 2013

28.0K

Related Experiment Videos

Last Updated: Aug 9, 2025

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.7K
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.5K
Remote Magnetic Navigation for Accurate, Real-time Catheter Positioning and Ablation in Cardiac Electrophysiology Procedures
09:13

Remote Magnetic Navigation for Accurate, Real-time Catheter Positioning and Ablation in Cardiac Electrophysiology Procedures

Published on: April 21, 2013

28.0K

Area of Science:

  • Invasive electrophysiology
  • Cardiac electrophysiology innovations
  • Catheter ablation technologies

Context:

  • Atrial fibrillation (AF) treatment is rapidly evolving.
  • New diagnostic guidelines for ventricular tachycardia (VT) were released in August 2022.
  • Technological advancements are enhancing cardiac rhythm management.

Purpose:

  • To review recent technical innovations in catheter ablation for AF.
  • To highlight advancements in VT diagnostics and treatment recommendations.
  • To discuss developments in cardiac pacing technologies, including leadless and conduction system pacing.

Summary:

  • Pulsed field ablation (PFA) offers rapid and effective AF treatment with high success and safety.
  • Very high-power short-duration (vHPSD) radiofrequency ablation (RF) protocols improve AF ablation efficiency.
  • Innovations in VT diagnostics align with new European guidelines, personalizing treatment for cardiomyopathies.
  • Conduction system pacing (CSP), including His-bundle and left bundle branch pacing (LBBP), benefits heart failure patients.
  • Leadless pacemakers demonstrate positive long-term outcomes, with emerging two-chamber approaches.

Impact:

  • PFA and advanced RF techniques are improving AF ablation efficacy and safety.
  • New VT guidelines and diagnostic tools enable personalized cardiomyopathy management.
  • Conduction system pacing and leadless pacemakers represent significant advancements in cardiac pacing.
  • These innovations collectively enhance the treatment of complex cardiac arrhythmias and heart failure.